• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > GBI Research
Publisher
Filter

GBI Research Report List

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include: ? Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research. ? Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography. ? Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered. ? Market Profiles: overview-level reports based on market, company and demographic data. ? Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.

Filter
Title Search
1 - 25 of 117 Products Sort by Display
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
633179
Published
April 30, 2018
Content info
82 Pages
Price
USD 3995
Sample available
Influenza A Viral Infections Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
633178
Published
April 30, 2018
Content info
188 Pages
Price
USD 3995
Sample available
Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease
Published by
GBI Research
Product code
630781
Published
April 1, 2018
Content info
77 Pages
Price
USD 6995
Sample available
Cognitive Impairment Disorders Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
630779
Published
April 1, 2018
Content info
376 Pages
Price
USD 3995
Sample available
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies
Published by
GBI Research
Product code
633177
Published
March 31, 2018
Content info
92 Pages
Price
USD 4995
Sample available
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs
Published by
GBI Research
Product code
516017
Published
March 31, 2018
Content info
181 Pages
Price
USD 4995
Sample available
Fungal Foot Infections Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
622433
Published
March 22, 2018
Content info
58 Pages
Price
USD 3995
Sample available
Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
622432
Published
March 22, 2018
Content info
159 Pages
Price
USD 3995
Sample available
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs
Published by
GBI Research
Product code
622434
Published
March 1, 2018
Content info
148 Pages
Price
USD 4995
Sample available
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential
Published by
GBI Research
Product code
614183
Published
February 7, 2018
Content info
199 Pages
Price
USD 4995
Sample available
Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market
Published by
GBI Research
Product code
611856
Published
February 1, 2018
Content info
91 Pages
Price
USD 4995
Sample available
Frontier Pharma: Women's Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline
Published by
GBI Research
Product code
611855
Published
February 1, 2018
Content info
86 Pages
Price
USD 6995
Sample available
Antibacterial Therapeutics - High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance
Published by
GBI Research
Product code
604380
Published
January 1, 2018
Content info
73 Pages
Price
USD 6995
Sample available
Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market
Published by
GBI Research
Product code
630780
Published
December 27, 2017
Content info
155 Pages
Price
USD 4995
Sample available
Lower Female Reproductive System Cancers Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
601161
Published
December 26, 2017
Content info
129 Pages
Price
USD 3995
Sample available
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
601160
Published
December 22, 2017
Content info
150 Pages
Price
USD 3995
Sample available
Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease
Published by
GBI Research
Product code
602312
Published
December 15, 2017
Content info
160 Pages
Price
USD 4995
Sample available
Frontier Pharma: Transplantation Therapeutics - A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation
Published by
GBI Research
Product code
599275
Published
December 1, 2017
Content info
72 Pages
Price
USD 6995
Sample available
Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape
Published by
GBI Research
Product code
599274
Published
December 1, 2017
Content info
228 Pages
Price
USD 4995
Sample available
COPD Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies
Published by
GBI Research
Product code
423017
Published
December 1, 2017
Content info
120 Pages
Price
USD 4995
Sample available
Swine and Avian Influenza Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
588366
Published
November 20, 2017
Content info
119 Pages
Price
USD 3995
Sample available
Sickle Cell Disease Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
588365
Published
November 17, 2017
Content info
77 Pages
Price
USD 3995
Sample available
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
588364
Published
November 16, 2017
Content info
244 Pages
Price
USD 3995
Sample available
Cancer Supportive Care Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
588363
Published
November 14, 2017
Content info
128 Pages
Price
USD 3995
Sample available
Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD
Published by
GBI Research
Product code
585550
Published
November 1, 2017
Content info
149 Pages
Price
USD 6995
Sample available